Skip to main content

Alveolar Bone Loss

0
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Medtronic
MedtronicNJ - Phillipsburg
2 programs
INFUSE® Bone GraftN/A1 trial
INFUSE® Bone GraftN/A1 trial
Active Trials
NCT00991432Terminated10Est. Mar 2011
NCT00991965Terminated8Est. Nov 2010
Innovation Pharmaceuticals
1 program
Xenogeneic Bone GraftN/A1 trial
Active Trials
NCT07474857Completed20Est. Dec 2024
Vericel
VericelCAMBRIDGE, MA
1 program
Tissue Repair CellsPHASE_1_21 trial
Active Trials
NCT00755911Completed24Est. May 2012
Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Conventional protocolPHASE_2_31 trial
Active Trials
NCT02120053Unknown37Est. Mar 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Geistlich PharmaConventional protocol
VericelTissue Repair Cells
Innovation PharmaceuticalsXenogeneic Bone Graft
MedtronicINFUSE® Bone Graft
MedtronicINFUSE® Bone Graft

Clinical Trials (5)

Total enrollment: 99 patients across 5 trials

NCT02120053Geistlich PharmaConventional protocol

Interest of Bone Substitute Material in Immediate Complete Denture

Start: Oct 2013Est. completion: Mar 201837 patients
Phase 2/3Unknown
NCT00755911VericelTissue Repair Cells

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

Start: Jun 2008Est. completion: May 201224 patients
Phase 1/2Completed
NCT07474857Innovation PharmaceuticalsXenogeneic Bone Graft

Anti-HLA Antibodies After Bone Regeneration Surgery

Start: Jul 2023Est. completion: Dec 202420 patients
N/ACompleted
NCT00991432MedtronicINFUSE® Bone Graft

Localized Alveolar Ridge Augmentation With Space Maintenance Devices

Start: Oct 2009Est. completion: Mar 201110 patients
N/ATerminated
NCT00991965MedtronicINFUSE® Bone Graft

Localized Alveolar Ridge Augmentation With Dental Implant

Start: Oct 2009Est. completion: Nov 20108 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.